Given this, the targeted inhibition of IGF-1R can also lead to metabolic abnormalities, such as hyperglycemia and insulin dysregulation, through the action of IGF-1R/IR-A hybrids [13,14]. This evidence concerns the gene IGF1R and Hyperglycemia.